Report Detail
Global Antibody Drug Conjugate Market Insights, Forecast to 2025
- RnM2363016 |
- 02 April, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
The global Antibody Drug Conjugate market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antibody Drug Conjugate market based on company, product type, end user and key regions.
This report studies the global market size of Antibody Drug Conjugate in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antibody Drug Conjugate in these regions.
This research report categorizes the global Antibody Drug Conjugate market by top players/brands, region, type and end user. This report also studies the global Antibody Drug Conjugate market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Seattle Genetics/Takeda
Roche
ImmunoGen
Immunomedics
Pfizer
Celldex Therapeutics
Millennium Pharmaceuticals
Bayer HealthCare
Mersana Therapeutics
Heidelberg Pharma
Oxford BioTherapeutics
Takeda Pharmaceutical Company Limited
Market size by Product
Adcetris
Kadcyl
Other
Market size by End User
Hospital
Pharmaceutical Company
Research Institutions
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Antibody Drug Conjugate market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Antibody Drug Conjugate market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Antibody Drug Conjugate companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Antibody Drug Conjugate submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Antibody Drug Conjugate are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antibody Drug Conjugate market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Antibody Drug Conjugate Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Antibody Drug Conjugate Market Size Growth Rate by Product
- 1.4.2 Adcetris
- 1.4.3 Kadcyl
- 1.4.4 Other
- 1.5 Market by End User
- 1.5.1 Global Antibody Drug Conjugate Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Pharmaceutical Company
- 1.5.4 Research Institutions
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Antibody Drug Conjugate Market Size
- 2.1.1 Global Antibody Drug Conjugate Revenue 2014-2025
- 2.1.2 Global Antibody Drug Conjugate Sales 2014-2025
- 2.2 Antibody Drug Conjugate Growth Rate by Regions
- 2.2.1 Global Antibody Drug Conjugate Sales by Regions
- 2.2.2 Global Antibody Drug Conjugate Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Antibody Drug Conjugate Sales by Manufacturers
- 3.1.1 Antibody Drug Conjugate Sales by Manufacturers
- 3.1.2 Antibody Drug Conjugate Sales Market Share by Manufacturers
- 3.1.3 Global Antibody Drug Conjugate Market Concentration Ratio (CR5 and HHI)
- 3.2 Antibody Drug Conjugate Revenue by Manufacturers
- 3.2.1 Antibody Drug Conjugate Revenue by Manufacturers (2014-2019)
- 3.2.2 Antibody Drug Conjugate Revenue Share by Manufacturers (2014-2019)
- 3.3 Antibody Drug Conjugate Price by Manufacturers
- 3.4 Antibody Drug Conjugate Manufacturing Base Distribution, Product Types
- 3.4.1 Antibody Drug Conjugate Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Antibody Drug Conjugate Product Type
- 3.4.3 Date of International Manufacturers Enter into Antibody Drug Conjugate Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Antibody Drug Conjugate Sales by Product
- 4.2 Global Antibody Drug Conjugate Revenue by Product
- 4.3 Antibody Drug Conjugate Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Antibody Drug Conjugate Breakdown Data by End User
6 North America
- 6.1 North America Antibody Drug Conjugate by Countries
- 6.1.1 North America Antibody Drug Conjugate Sales by Countries
- 6.1.2 North America Antibody Drug Conjugate Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Antibody Drug Conjugate by Product
- 6.3 North America Antibody Drug Conjugate by End User
7 Europe
- 7.1 Europe Antibody Drug Conjugate by Countries
- 7.1.1 Europe Antibody Drug Conjugate Sales by Countries
- 7.1.2 Europe Antibody Drug Conjugate Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Antibody Drug Conjugate by Product
- 7.3 Europe Antibody Drug Conjugate by End User
8 Asia Pacific
- 8.1 Asia Pacific Antibody Drug Conjugate by Countries
- 8.1.1 Asia Pacific Antibody Drug Conjugate Sales by Countries
- 8.1.2 Asia Pacific Antibody Drug Conjugate Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Antibody Drug Conjugate by Product
- 8.3 Asia Pacific Antibody Drug Conjugate by End User
9 Central & South America
- 9.1 Central & South America Antibody Drug Conjugate by Countries
- 9.1.1 Central & South America Antibody Drug Conjugate Sales by Countries
- 9.1.2 Central & South America Antibody Drug Conjugate Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Antibody Drug Conjugate by Product
- 9.3 Central & South America Antibody Drug Conjugate by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Antibody Drug Conjugate by Countries
- 10.1.1 Middle East and Africa Antibody Drug Conjugate Sales by Countries
- 10.1.2 Middle East and Africa Antibody Drug Conjugate Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Antibody Drug Conjugate by Product
- 10.3 Middle East and Africa Antibody Drug Conjugate by End User
11 Company Profiles
- 11.1 Seattle Genetics/Takeda
- 11.1.1 Seattle Genetics/Takeda Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Seattle Genetics/Takeda Antibody Drug Conjugate Products Offered
- 11.1.5 Seattle Genetics/Takeda Recent Development
- 11.2 Roche
- 11.2.1 Roche Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Roche Antibody Drug Conjugate Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Roche Antibody Drug Conjugate Products Offered
- 11.2.5 Roche Recent Development
- 11.3 ImmunoGen
- 11.3.1 ImmunoGen Company Details
- 11.3.2 Company Business Overview
- 11.3.3 ImmunoGen Antibody Drug Conjugate Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 ImmunoGen Antibody Drug Conjugate Products Offered
- 11.3.5 ImmunoGen Recent Development
- 11.4 Immunomedics
- 11.4.1 Immunomedics Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Immunomedics Antibody Drug Conjugate Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Immunomedics Antibody Drug Conjugate Products Offered
- 11.4.5 Immunomedics Recent Development
- 11.5 Pfizer
- 11.5.1 Pfizer Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Pfizer Antibody Drug Conjugate Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Pfizer Antibody Drug Conjugate Products Offered
- 11.5.5 Pfizer Recent Development
- 11.6 Celldex Therapeutics
- 11.6.1 Celldex Therapeutics Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Celldex Therapeutics Antibody Drug Conjugate Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Celldex Therapeutics Antibody Drug Conjugate Products Offered
- 11.6.5 Celldex Therapeutics Recent Development
- 11.7 Millennium Pharmaceuticals
- 11.7.1 Millennium Pharmaceuticals Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Millennium Pharmaceuticals Antibody Drug Conjugate Products Offered
- 11.7.5 Millennium Pharmaceuticals Recent Development
- 11.8 Bayer HealthCare
- 11.8.1 Bayer HealthCare Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Bayer HealthCare Antibody Drug Conjugate Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Bayer HealthCare Antibody Drug Conjugate Products Offered
- 11.8.5 Bayer HealthCare Recent Development
- 11.9 Mersana Therapeutics
- 11.9.1 Mersana Therapeutics Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Mersana Therapeutics Antibody Drug Conjugate Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Mersana Therapeutics Antibody Drug Conjugate Products Offered
- 11.9.5 Mersana Therapeutics Recent Development
- 11.10 Heidelberg Pharma
- 11.10.1 Heidelberg Pharma Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Heidelberg Pharma Antibody Drug Conjugate Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Heidelberg Pharma Antibody Drug Conjugate Products Offered
- 11.10.5 Heidelberg Pharma Recent Development
- 11.11 Oxford BioTherapeutics
- 11.12 Takeda Pharmaceutical Company Limited
12 Future Forecast
- 12.1 Antibody Drug Conjugate Market Forecast by Regions
- 12.1.1 Global Antibody Drug Conjugate Sales Forecast by Regions 2019-2025
- 12.1.2 Global Antibody Drug Conjugate Revenue Forecast by Regions 2019-2025
- 12.2 Antibody Drug Conjugate Market Forecast by Product
- 12.2.1 Global Antibody Drug Conjugate Sales Forecast by Product 2019-2025
- 12.2.2 Global Antibody Drug Conjugate Revenue Forecast by Product 2019-2025
- 12.3 Antibody Drug Conjugate Market Forecast by End User
- 12.4 North America Antibody Drug Conjugate Forecast
- 12.5 Europe Antibody Drug Conjugate Forecast
- 12.6 Asia Pacific Antibody Drug Conjugate Forecast
- 12.7 Central & South America Antibody Drug Conjugate Forecast
- 12.8 Middle East and Africa Antibody Drug Conjugate Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Antibody Drug Conjugate Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Antibody Drug Conjugate . Industry analysis & Market Report on Antibody Drug Conjugate is a syndicated market report, published as Global Antibody Drug Conjugate Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Antibody Drug Conjugate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
